Using budding yeast to screen for anti-prion drugs

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Prions are misfolded proteins causing fatal neurodegenerative diseases like transmissible spongiform encephalopathies.
• No effective treatments currently exist for prion-based diseases.
• Prion propagation mechanisms are not fully understood but are critical for disease development.

Purpose of the Study:

• To develop and validate a rapid, cost-effective, high-throughput screening method for identifying anti-prion compounds.
• To identify novel drug candidates for treating prion diseases.
• To explore conserved pathways in prion formation and maintenance.

Main Methods:

• A two-step, yeast-based assay was developed for screening potential anti-prion drugs.
• Compounds were tested in vivo against budding yeast prions ([PSI+] and [URE3]).
• Efficacy was further assessed by evaluating mammalian prion clearance in three cell culture models.

Main Results:

• The yeast-based assay successfully identified compounds effective against yeast prions.
• Several identified compounds also promoted mammalian prion clearance in cell culture.
• The results validate the assay as an efficient tool for drug discovery and structure-activity relationship studies.

Conclusions:

• The developed yeast assay is a validated, economic, and efficient high-throughput screening method for prion inhibitors.
• Conserved biochemical pathways suggest potential for pharmacological intervention across species.
• Identified compounds warrant further investigation in models of other amyloid-related diseases, including Alzheimer's and Parkinson's.